These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2177598)

  • 21. Assessment of screening tests for transfusion-associated non-A non-B hepatitis.
    Fleurette F; Durieux P; Battista RN; Benhamou JP; Degos F; Brechot C; Courouce AM; Janot C; Trepo C
    Int J Technol Assess Health Care; 1993; 9(4):479-89. PubMed ID: 7507096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis.
    Esteban JI; González A; Hernández JM; Viladomiu L; Sánchez C; López-Talavera JC; Lucea D; Martin-Vega C; Vidal X; Esteban R
    N Engl J Med; 1990 Oct; 323(16):1107-12. PubMed ID: 2170839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [International status of anti-HCV screening and conclusions].
    Habibi B
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):379-82. PubMed ID: 2177603
    [No Abstract]   [Full Text] [Related]  

  • 24. [Post-transfusional hepatitis].
    González A; Esteban JI
    Sangre (Barc); 1993 Jun; 38(3):193-200. PubMed ID: 7692610
    [No Abstract]   [Full Text] [Related]  

  • 25. [Post-transfusion non-A, non-B hepatitis: towards risk zero].
    de Andrade Júnior DR; de Andrade DR
    Arq Gastroenterol; 1992; 29(1):1-4. PubMed ID: 1284884
    [No Abstract]   [Full Text] [Related]  

  • 26. [Practical approach to the discovery of a positive HCV serology in a blood donor].
    Elghouzzi MH; Giral P; Opolon P; Trepo C; Poupon R; Jullien AM
    Rev Fr Transfus Hemobiol; 1991 Jul; 34(4):315-42. PubMed ID: 1654911
    [No Abstract]   [Full Text] [Related]  

  • 27. Infectivity of blood seropositive for hepatitis C virus antibodies.
    van der Poel CL; Reesink HW; Schaasberg W; Leentvaar-Kuypers A; Bakker E; Exel-Oehlers PJ; Lelie PN
    Lancet; 1990 Mar; 335(8689):558-60. PubMed ID: 1968574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
    Chung HT; Lee JS; Lok AS
    Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prevention for hepatitis C virus transmission].
    Sekiguchi S
    Hokkaido Igaku Zasshi; 1993 Jul; 68(4):473-6. PubMed ID: 7687974
    [No Abstract]   [Full Text] [Related]  

  • 30. Hepatitis C virus: routes of infection and genotypes in a cohort of anti-HCV-positive French blood donors.
    Elghouzzi MH; Bouchardeau F; Pillonel J; Boiret E; Tirtaine C; Barlet V; Moncharmont P; Maisonneuve P; du Puy-Montbrun MC; Lyon-Caen D; Couroucé AM
    Vox Sang; 2000; 79(3):138-44. PubMed ID: 11111231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibodies to hepatitis C virus in Cuban blood donors.
    Rivero RA; Hedalgo-Gato R; Martinez M; Hernandez P; Ballester JM; Yamaguchi K; Fukuyoshi Y; Kiyokawa T; Takatsuki K
    Vox Sang; 1992; 63(4):285-6. PubMed ID: 1282758
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prevention of post-transfusion hepatitis non-A, non-B. Report established by the National Agency for the Development of Medical Evaluation on demand of the General Health Direction].
    Gayno S
    Gastroenterol Clin Biol; 1991; 15(8-9):667-8. PubMed ID: 1752387
    [No Abstract]   [Full Text] [Related]  

  • 33. History of posttransfusion hepatitis.
    Tobler LH; Busch MP
    Clin Chem; 1997 Aug; 43(8 Pt 2):1487-93. PubMed ID: 9265899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Significance of alanine aminotransferase screening in blood donors for risk reduction of hepatitis B and C transmission by haemotherapy].
    Kusendová K; Gavorník P; Sabaka P; Sviteková K
    Vnitr Lek; 2016 Jan; 62(1):9-16. PubMed ID: 26967232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [HCV antibodies in selected patient groups and blood donors].
    Courault K; Lisse C; Ehrenberg M; Stolle K; Brandstädter W; Fritzsche L
    Beitr Infusionsther; 1991; 28():22-4. PubMed ID: 1725624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of the blood supply. Surrogate testing and transmission of hepatitis C in patients after massive transfusion.
    Morris JA; Wilcox TR; Reed GW; Hunter EB; Wallas CH; Steane EA; Shotts SD; Vitsky JL
    Ann Surg; 1994 May; 219(5):517-25; discussion 525-6. PubMed ID: 7514394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Serological study on hepatitis C (HCV) in 4371 blood donors].
    Arnone M; Pinducciu G; Usai M; Pitzus F; Pintus L
    Ann Ig; 1990; 2(5):353-8. PubMed ID: 1715726
    [No Abstract]   [Full Text] [Related]  

  • 38. Epidemiology of anti-HCV antibodies in France. Viral Hepatitis Study Group of the French Blood Transfusion Society.
    Aguelles O; Janot C
    Arch Virol Suppl; 1992; 4():249-52. PubMed ID: 1450696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-hepatitis C antibodies in prospectively followed-up transfused patients.
    Couroucé AM; Jullien AM; Vedrenne JB; Habibi B
    Vox Sang; 1990; 58(3):226-7. PubMed ID: 2111065
    [No Abstract]   [Full Text] [Related]  

  • 40. [Public Health Council advisory: prevention of post-transfusion non-A non-B hepatitis; is application of a surrogate test a missed station?].
    Brandt KH
    Ned Tijdschr Geneeskd; 1989 Nov; 133(45):2212-4. PubMed ID: 2509949
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.